News

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans. The agency is changing ...
A vaccine that helps people overcome cocaine addiction has shown signs of being safe and effective in a small trial ...
The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...
The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...